China Economic Weekly has released the latest ranking of China's most profitable A-share bio-med companies. Shanghai Pharmaceuticals came out as the biggest winner, with a net profit of 2.46 billion yuan (US$401 million).

Similar to 2011, Shanghai Pharmaceuticals was the only bio-med company on the overall list of the 100 most profitable A-share public companies in China 2012. Due to its outstanding performance, the company climbed up to the 81st spot on the industrial ranking from 2011's 83rd place.

Shanghai Fosun Pharmaceutical ranked 2nd on the list, followed by Yunnan Baiyao.

Based on the 2012 annual reports of China's public companies, total net profits of the top 10 bio-med companies achieved certain growth from 2011.

The following are China's top ten most profitable A-share bio-med companies in 2012.

 Zhejiang Medicine（浙江醫(yī)藥）

Zhejiang Medicine [tupian.baike.com]

Stock code: 600216.SH

Net profit: 851 million yuan (US$138.75 million)

Time of listing: Oct. 21, 1999

Headquarters: Hangzhou, Zhejiang Province